Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 NOK | -2.27% | +0.94% | -17.94% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2021 | 87.62M 7.96M | Sales 2022 | 120M 10.94M | Capitalization | 1.3B 118M |
---|---|---|---|---|---|
Net income 2021 | -126M -11.44M | Net income 2022 | -137M -12.44M | EV / Sales 2021 | 29.2 x |
Net Debt 2021 | 89.26M 8.11M | Net Debt 2022 | 71.74M 6.52M | EV / Sales 2022 | 11.4 x |
P/E ratio 2021 |
-19.5
x | P/E ratio 2022 |
-8.89
x | Employees | 60 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 41.78% |
1 day | -2.27% | ||
1 week | +0.94% | ||
Current month | +3.37% | ||
1 month | -6.52% | ||
3 months | -18.87% | ||
6 months | -21.25% | ||
Current year | -17.94% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 2.15 | -2.27% | 2,551 |
24-04-18 | 2.2 | +4.76% | 155,683 |
24-04-17 | 2.1 | -0.94% | 230,409 |
24-04-16 | 2.12 | -1.40% | 13,107 |
24-04-15 | 2.15 | +0.94% | 25,481 |
Real-time Oslo Bors, April 19, 2024 at 10:45 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-17.94% | 77.15M | |
-2.33% | 275B | |
-5.96% | 91.62B | |
+2.16% | 45.93B | |
+1.30% | 40.7B | |
+8.11% | 39.76B | |
-0.76% | 37.78B | |
-13.32% | 31.41B | |
-8.36% | 28.18B | |
+3.38% | 22.71B |
- Stock Market
- Equities
- HBC Stock